Wednesday, November 20, 2024
FDA Panel Votes 14-1 Against Clozapine REMS
›
A panel convened by the Food and Drug Administration (FDA) voted overwhelmingly yesterday against key provisions of the Clozapine Risk Eval...
Tuesday, November 19, 2024
For Coordinated Specialty Care, Fidelity to Program Components Matters
›
Individuals with first-episode psychosis who received the wide range of services provided in coordinated specialty care (CSC) programs expe...
Monday, November 18, 2024
DEA, HHS Issue Third Extension of Pandemic Telehealth Prescribing Flexibilities
›
On Friday the Drug Enforcement Administration (DEA) in concert with the U.S. Department of Health and Human Services (HHS) issued a third e...
Friday, November 15, 2024
Pandemic-Fueled Rise in Drinking Persisted Into 2022
›
Alcohol consumption among adults increased during the early part of the COVID pandemic, and this increase was sustained two years later, ac...
Thursday, November 14, 2024
Hallucinogen-Related ED Visits Associated With Schizophrenia Risk
›
Individuals who require emergency care after using hallucinogenic drugs have an increased risk of developing a schizophrenia spectrum disor...
›
Home
View web version
